181 related articles for article (PubMed ID: 35595050)
1. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
[TBL] [Abstract][Full Text] [Related]
2. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome.
Rosário C; Zandman-Goddard G; Meyron-Holtz EG; D'Cruz DP; Shoenfeld Y
BMC Med; 2013 Aug; 11():185. PubMed ID: 23968282
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco S; Alessandri C; Conti F; Priori R
Autoimmun Rev; 2020 Jul; 19(7):102573. PubMed ID: 32387470
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
[TBL] [Abstract][Full Text] [Related]
5. Ferritin, fever, and frequent visits: Hyperferritinemic syndromes in the emergency department.
Annous Y; Manning S; Khoujah D
Am J Emerg Med; 2021 Oct; 48():249-254. PubMed ID: 34000525
[TBL] [Abstract][Full Text] [Related]
6. Ferritin and Severe COVID-19, from Clinical Observations to Pathogenic Implications and Therapeutic Perspectives.
Ruscitti P; Giacomelli R
Isr Med Assoc J; 2020 Aug; 22(8):516-518. PubMed ID: 33236586
[TBL] [Abstract][Full Text] [Related]
7. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno A; Carubbi F; Rodríguez-Carrio J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
Front Immunol; 2020; 11():603389. PubMed ID: 33552062
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
Gulzar M; Sabir A; Hamdani MA; Saadia A
J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Plate A; Vallelian F; Herfs G
Praxis (Bern 1994); 2016; 105(25):1503-1506. PubMed ID: 27976958
[No Abstract] [Full Text] [Related]
11. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
12. Hyperferritinemic syndrome: Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients.
Betancur JF; Navarro EP; Echeverry A; Moncada PA; Cañas CA; Tobón GJ
Clin Rheumatol; 2015 Nov; 34(11):1989-92. PubMed ID: 26233722
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
14. Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis.
Fan Z; Kernan KF; Qin Y; Canna S; Berg RA; Wessel D; Pollack MM; Meert K; Hall M; Newth C; Lin JC; Doctor A; Shanley T; Cornell T; Harrison RE; Zuppa AF; Sward K; Dean JM; Park HJ; Carcillo JA
Crit Care; 2023 Sep; 27(1):347. PubMed ID: 37674218
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
Kondo Y; Kaneko Y; Takei H; Tamai H; Kabata H; Suhara T; Yamamoto R; Nagata H; Ishii M; Sasaki J; Hasegawa N; Fukunaga K; Takeuchi T;
Clin Exp Rheumatol; 2021; 39(3):631-638. PubMed ID: 33886458
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
Perricone C; Bartoloni E; Bursi R; Cafaro G; Guidelli GM; Shoenfeld Y; Gerli R
Immunol Res; 2020 Aug; 68(4):213-224. PubMed ID: 32681497
[TBL] [Abstract][Full Text] [Related]
17. ["STILL IS NOT ENOUGH" - WHAT IS THE DIFFERENTIAL DIAGNOSIS AND THE WORKUP WHEN THE FERRITIN LEVEL IS EXTREMELY HIGH?].
Cohen D; Mansour R; Amital H; Segal G
Harefuah; 2020 Mar; 159(3):166-169. PubMed ID: 32186785
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging biological therapy in adult-onset Still's disease.
Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
